Sapiens International Corporation N.V.  

(Public, NASDAQ:SPNS)   Watch this stock  
Find more results for SPNS
13.11
0.00 (0.00%)
Sep 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 10.57 - 15.98
Open     -
Vol / Avg. 0.00/44,095.00
Mkt cap 642.86M
P/E 191.81
Div/yield 0.20/6.10
EPS 0.07
Shares 49.04M
Beta 1.20
Inst. own 18%
Nov 8, 2017
Q3 2017 Sapiens International Corporation NV Earnings Release (Estimated) Add to calendar
Aug 7, 2017
Q2 2017 Sapiens International Corporation NV Earnings Call - Webcast
Aug 7, 2017
Q2 2017 Sapiens International Corporation NV Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -5.19% 9.07%
Operating margin -4.32% 11.49%
EBITD margin - 16.13%
Return on average assets -4.18% 7.84%
Return on average equity -7.20% 10.33%
Employees 1,928 -
CDP Score - -

Address

Azrieli Center, 26 Harokmim
HOLON, 5885800
Israel
+972-3-7902000 (Phone)
+972-3-7902942 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Sapiens International Corporation N.V. (Sapiens) is a provider of software solutions for the insurance industry, with a focus on the financial services sector. The Company operates in provider of software solutions segment. Its software solutions portfolio consists of Life, Pension, Annuity and Retirement Solutions, including software solutions for the management of a range of products for life, pension, annuity and retirement; Property and Casualty/General Insurance Solutions, including a software suite of solutions, supporting a range of business lines, including personal, commercial and specialty lines, as well as a solution for the management of reinsurance contracts; Sapiens DECISION, which is a business decision management solution, and Technology-Based Solutions, such as Sapiens eMerge. Its services include project delivery and implementation, business and technical consulting related to its products, project and program management, training and user acceptance testing.

Officers and directors

Guy Bernstein Chairman of the Board
Age: 48
Bio & Compensation  - Reuters
Roni Al Dor President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Roni Giladi Chief Financial Officer
Age: 42
Bio & Compensation  - Reuters
Scott Palmer Executive Vice President - Retirement Services
Bio & Compensation  - Reuters
Steve Rooney Executive Vice President-Global Sales
Bio & Compensation  - Reuters
Naamit Salomon Director
Age: 50
Bio & Compensation  - Reuters
Eyal Ben-Chelouche Independent Director
Age: 51
Bio & Compensation  - Reuters
Yacov Elinav Independent Director
Age: 72
Bio & Compensation  - Reuters
Uzi Netanel Independent Director
Age: 81
Bio & Compensation  - Reuters